Robert J. Mulroy
Fundador en Partner Therapeutics, Inc. .
Cargos activos de Robert J. Mulroy
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Fundador | - | - |
Historial de carrera de Robert J. Mulroy
Antiguos cargos conocidos de Robert J. Mulroy.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 27/01/2011 | 03/10/2016 |
| Director Ejecutivo | 01/05/1999 | 03/10/2016 | |
| Presidente | 01/05/1999 | 03/10/2016 |
Formación de Robert J. Mulroy.
| Stanford University | Undergraduate Degree |
| Yale University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert J. Mulroy
- Experiencia
